PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 209 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $303,000 | -13.7% | 5,000 | -0.2% | 0.00% | -20.0% |
| Q1 2021 | $351,000 | +17.0% | 5,010 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $300,000 | -0.7% | 5,010 | -0.1% | 0.01% | -16.7% |
| Q3 2020 | $302,000 | +15.3% | 5,017 | +0.3% | 0.01% | +20.0% |
| Q2 2020 | $262,000 | +23.0% | 5,000 | +2.0% | 0.01% | +66.7% |
| Q2 2019 | $213,000 | -19.0% | 4,900 | -29.0% | 0.00% | -25.0% |
| Q1 2019 | $263,000 | -23.5% | 6,900 | -13.8% | 0.00% | -20.0% |
| Q4 2018 | $344,000 | -30.1% | 8,000 | -20.0% | 0.01% | -16.7% |
| Q3 2018 | $492,000 | -5.4% | 10,000 | -34.2% | 0.01% | 0.0% |
| Q3 2016 | $520,000 | -49.3% | 15,200 | -50.0% | 0.01% | 0.0% |
| Q2 2016 | $1,026,000 | +27.5% | 30,400 | +100.0% | 0.01% | -45.5% |
| Q1 2016 | $805,000 | -11.9% | 15,200 | +27.7% | 0.01% | -8.3% |
| Q4 2015 | $914,000 | +1.3% | 11,900 | -6.7% | 0.01% | +9.1% |
| Q2 2015 | $902,000 | -33.6% | 12,750 | -16.6% | 0.01% | -31.2% |
| Q1 2015 | $1,358,000 | +13.5% | 15,280 | +13.2% | 0.02% | +23.1% |
| Q4 2014 | $1,197,000 | – | 13,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |